These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 799469

  • 1. Immunological aspects of hepatitis B virus infection.
    Edgington TS, Chisari FV.
    Am J Med Sci; 1975; 270(2):212-27. PubMed ID: 799469
    [Abstract] [Full Text] [Related]

  • 2. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH.
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [Abstract] [Full Text] [Related]

  • 3. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection.
    Ferrari C, Penna A, Bertoletti A, Valli A, Antoni AD, Giuberti T, Cavalli A, Petit MA, Fiaccadori F.
    J Immunol; 1990 Nov 15; 145(10):3442-9. PubMed ID: 2230128
    [Abstract] [Full Text] [Related]

  • 4. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
    Isaguliants MG, Kadoshnikov YP, Kalinina TI, Smirnov VD, Wahren B.
    Biochemistry (Mosc); 1998 May 15; 63(5):551-8. PubMed ID: 9632891
    [Abstract] [Full Text] [Related]

  • 5. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.
    Eggink HF, Houthoff HJ, Huitema S, Wolters G, Poppema S, Gips CH.
    Clin Exp Immunol; 1984 Apr 15; 56(1):121-8. PubMed ID: 6713726
    [Abstract] [Full Text] [Related]

  • 6. The immunopathogenesis of HBV infection.
    Koziel MJ.
    Antivir Ther; 1998 Apr 15; 3(Suppl 3):13-24. PubMed ID: 10726052
    [Abstract] [Full Text] [Related]

  • 7. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R, Fowler P, Guilhot S, Missale G, Cerny A, Schlicht HJ, Vitiello A, Chesnut R, Person JL, Redeker AG, Chisari FV.
    J Immunol; 1993 May 15; 150(10):4659-71. PubMed ID: 7683326
    [Abstract] [Full Text] [Related]

  • 8. The immune response induced by hepatitis B virus principal antigens.
    Huang CF, Lin SS, Ho YC, Chen FL, Yang CC.
    Cell Mol Immunol; 2006 Apr 15; 3(2):97-106. PubMed ID: 16696896
    [Abstract] [Full Text] [Related]

  • 9. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
    Bihl F, Loggi E, Chisholm JV, Biselli M, Morelli MC, Cursaro C, Terrault NA, Bernardi M, Bertoletti A, Andreone P, Brander C.
    Liver Transpl; 2008 Apr 15; 14(4):478-85. PubMed ID: 18324666
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis B core antigen and antibody.
    Hoofnagle JH, Gerety RJ, Barker LF.
    Dev Biol Stand; 1975 Apr 15; 30():175-85. PubMed ID: 1204955
    [Abstract] [Full Text] [Related]

  • 11. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
    Gotsman I, Alper R, Klein A, Rabbani E, Engelhardt D, Ilan Y.
    Cancer; 2002 Jan 15; 94(2):406-14. PubMed ID: 11900226
    [Abstract] [Full Text] [Related]

  • 12. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma.
    Böcher WO, Herzog-Hauff S, Schlaak J, Meyer zum Büschenfeld KH, Löhr HF.
    Hepatology; 1999 Jan 15; 29(1):238-44. PubMed ID: 9862872
    [Abstract] [Full Text] [Related]

  • 13. Specific immunotherapy proposed for hepatitis B virus infection.
    Vyas GN, Schmid R, Ibrahim AB, Rao KR.
    Dev Biol Stand; 1975 Jan 15; 30():350-6. PubMed ID: 1204970
    [Abstract] [Full Text] [Related]

  • 14. Carrier state of hepatitis B virus--an interesting host-parasite relationship.
    Iwarson S.
    Scand J Infect Dis Suppl; 1980 Jan 15; Suppl 24():128-30. PubMed ID: 6937975
    [Abstract] [Full Text] [Related]

  • 15. Immunopathology of hepatitis B antigen positive and negative active chronic hepatitis.
    Williams R.
    Dev Biol Stand; 1975 Jan 15; 30():341-9. PubMed ID: 1081961
    [Abstract] [Full Text] [Related]

  • 16. [Action mechanism in immunopathogenesis and clearance of HBV].
    Im SJ, Sung YC.
    Korean J Hepatol; 2006 Jun 15; 12(2):154-62. PubMed ID: 16804340
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis B virus gene products as immunological targets in chronic infection.
    Feitelson MA.
    Mol Biol Med; 1989 Oct 15; 6(5):367-93. PubMed ID: 2696858
    [Abstract] [Full Text] [Related]

  • 18. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY, Chang MH, Hsieh RP, Ni YH, Chi WK.
    Hepatology; 1996 Dec 15; 24(6):1355-60. PubMed ID: 8938161
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections.
    Chisari FV, Routenberg JA, Edgington TS.
    J Clin Invest; 1976 May 15; 57(5):1227-38. PubMed ID: 1083396
    [Abstract] [Full Text] [Related]

  • 20. Cellular immune responses in patients with dual infection of hepatitis B and C viruses: dominant role of hepatitis C virus.
    Tsai SL, Liaw YF, Yeh CT, Chu CM, Kuo GC.
    Hepatology; 1995 Apr 15; 21(4):908-12. PubMed ID: 7535736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.